Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Evidence for joint action of genes on diabetes status and CVD risk factors in American Indians: the Strong Heart Family Study

Abstract

OBJECTIVES: Previous research among American Indians of the strong heart family study (SHFS) has demonstrated significant heritabilities for CVD risk factors and implicated diabetes as an important predictor of several of the phenotypes. Moreover, we recently demonstrated that genetic effects on CVD risk factors differed in diabetic and nondiabetic individuals. In this paper, we investigated whether a significant genetic influence on diabetes status could be identified, and whether there is evidence for joint action of genes on diabetes status and related CVD risk factors.

METHODS AND RESULTS: Approximately 950 men and women, age 18 or older, in 32 extended families, were examined between 1997 and 1999. We estimated the effects of genes and environmental covariates on diabetes status using a threshold model and a maximum likelihood variance component approach. Diabetes status exhibited a residual heritability of 22% (h2=0.22). We also estimated the genetic and environmental correlations between diabetes susceptibility and eight risk factors for CVD. All eight CVD risk factors displayed significant genetic correlations with diabetes status (BMI (ρG=0.55), fibrinogen (ρG=0.40), HDL-C (ρG=−0.37), ln triglycerides (ρG=0.65), FAT (ρG=0.38), PAI-1 (ρG=0.67), SBP (ρG=0.57), and WHR (ρG=0.58)). Three of eight traits (HDL-C (ρE=−0.32), ln triglycerides (ρE=0.33), and fibrinogen (ρE=0.20)) displayed significant environmental correlations with diabetes status.

CONCLUSIONS: These findings suggest that in the context of a high prevalence of diabetes, still unidentified diabetes genes may play an important role in influencing variation in CVD risk factors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Carr ME . Diabetes mellitus: a hypercoagulable state. J Diabetes Complicat 2001; 15: 44–54.

    Article  CAS  Google Scholar 

  2. Galloway JM, Alpert JS . Coronary artery disease and hypertension. In: Galloway JM, Goldberg BW, Alpert JS (eds). Primary care of Native American patients: diagnosis, therapy, and epidemiology. Woburn, MA: Butterwoth-Heinemann, 1999, pp 125–131.

    Google Scholar 

  3. Welty TK, Rhoades D, Lee ET, Yeh F, Cowan LD, Fabsitz R, Robbins DC, Devereux RB, Henderson JA, Crawford AS, Howard BV . Changes in cardiovascular risk factors among American Indians: the strong heart study. Ann Epidemiol 2002; 12: 97–106.

    Article  PubMed  Google Scholar 

  4. Lee ET, Cowan LD, Welty TK, Sievers M, Howard WJ, Oopik A, Wang W, Yeh J, Devereux RB, Rhoades ER, Fabsitz RR, Go OT, Howard BV . All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45–74 years, 1984–88: the strong heart study. Am J Epidemiol 1998; 147: 995–1008.

    Article  CAS  PubMed  Google Scholar 

  5. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, Howard WJ, Rhoades ER, Robbins DC, Sievers ML, Welty TK . Rising tide of cardiovascular disease in American Indians. The strong heart study. Circulation 1999; 99: 2389–2395.

    Article  CAS  PubMed  Google Scholar 

  6. North KE, Howard BV, Best L, Lee ET, Fabsitz RR, MacCluer JW . Genetic and environmental contributions to cardiovascular disease risk factors in American Indians: the strong heart family study. Am J Epidemiol 157: 303–314.

  7. North KE, MacCluer JW, Best L, Welty TK, Lee ET, Fabsitz RR, Howard BV . Evidence for distinct genetic effects on obesity and lipid related CVD risk factors in diabetic and non-diabetic American Indians: the strong heart family study. Diabetes Metab Res Rev 2003, (in press).

  8. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP . Linkage of type 2 diabetes mellitus and age on onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 1999; 64: 1127–1140.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lee ET, Howard BV, Savage PJ, Cowan LD, Fabsitz RR, Oopik AJ, Yeh J, Go O, Robbins DC, Welty TK . Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. Diabetes Care 1995; 18: 599–610.

    Article  CAS  PubMed  Google Scholar 

  10. Diehl AK, Stern MP . Special health problems of Mexican Americans: obesity, gallbladder disease, diabetes mellitus, and cardiovascular disease. Adv Intern Med 1989; 34: 73–96.

    CAS  PubMed  Google Scholar 

  11. Chakraborty R, Ferrell RE, Stern MP, Haffner SM, Hazuda HP, Rosenthal M . Relationship of prevalence of non-insulin dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas. Genet Epidemiol 1986; 3: 435–454.

    Article  CAS  PubMed  Google Scholar 

  12. Brosseau JD, Eelkema RC, Crawford AC, Abe TA . Diabetes among the three affiliated tribes: correlations with degree of Indian inheritance. Am J Public Health 1979; 69: 1277–1278.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Knowler WC, Williams RC, Pettit DJ, Steinberg AG . Gm3,5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet 1988; 43: 520–526.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Barnett AH, Eff C, Lesline RDG, Pyke AA . Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981; 20: 87–93.

    Article  CAS  PubMed  Google Scholar 

  15. Newman B, Sekby JV, King MC, Slemenda C, Fabsitz R, Friedman GD . Concordance for type II (NIDDM) in male twins. Diabetologia 1987; 30: 763–768.

    Article  CAS  PubMed  Google Scholar 

  16. Kaprio J, Tuomilehto J, Koskenvou M . Concordance for type 1 (insulin dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992; 30: 763–768.

    Google Scholar 

  17. Rewers M, Hamman RF . Risk factors for NIDDM. National Diabetes Data Group. Diabetes in America, 2nd edn. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. NIH Publication no. 95-1468; 1995.

  18. Knowler WC, Pettitt DL, Savage PJ, Bennett PH . Diabetes incidence in Pima Indians: contributions of obesity and parental diabetics. Am J Epidemiol 1981; 113: 144–156.

    Article  CAS  PubMed  Google Scholar 

  19. Lee ET, Anderson PS, Bryan J . Diabetes, parental diabetes, and obesity in Oklahoma Indians. Diabetes Care 1985; 8: 107–113.

    Article  CAS  PubMed  Google Scholar 

  20. Warram JH, Martin BC, Soeldner JS, Krolewski AS . Study of glucose removal rate and first phase insulin secretion in the offspring of two parents with NIDDM. In: Camerini-Davalos RA, Cole HS (eds). Adv Exp Med Biol 1988; 246: 175–183.

    Article  CAS  PubMed  Google Scholar 

  21. Hsueh W, Mitchell BD, Aburomia R, Pollin T, Sakul H, Ehm MG, Michelsen BK, Wagner MJ, St Jean PL, Knowler WC, Burns DK, Bell CJ, Shuldiner AR . Diabetes in the old order Amish. Characterization and heritability analysis of the Amish Diabetes Study. Diabetes Care 2000; 23: 595–601.

    Article  CAS  PubMed  Google Scholar 

  22. Duggirala R, Williams JT, Williams-Blangero S, Blangero J . A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol 1997; 14: 987–992.

    Article  CAS  PubMed  Google Scholar 

  23. Williams JT, Van Eerdewegh P, Almasy L, Blangero J . Joint multipoint analysis of multivariate qualitative and quantitative traits. I. Likelihood formation and simulation results. Am J Hum Genet 1999; 65: 1134–1147.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lee ET, Welty TK, Fabsitz RR, Cowan LD, Le N, Oopik AV, Cucchiara AJ, Savage PJ, Howard BV . The Strong Heart Study A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990; 132: 1141–1155.

    Article  CAS  PubMed  Google Scholar 

  25. Howard BV, Lee ET, Cowan L, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK . Coronary heart disease prevalence and its relation to heart disease in American Indians: the Strong Heart Study. Am J Epidemiol 1995; 142: 254–268.

    Article  CAS  PubMed  Google Scholar 

  26. Liedtke RJ . Principles of bioelectric independence analysis. 1997, www.rjlsystems.com/research/bia-principles.html.

  27. Howard BV, Welty TK, Fabsitz RR, Cowan LD, Oopik AJ, Le NA, Yeh J, Savage PJ, Lee ET . Risk factors for coronary heart disease in diabetic and non-diabetic Native Americans: The Strong Heart Study. Diabetes 1992; 41(Suppl 2): 4–11.

    Article  PubMed  Google Scholar 

  28. Friedwald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    Google Scholar 

  29. Geffken D, Keating F, Kennedy M, Cornell E, Bovill E, Tracy R . The measurement of fibrinogen in population-based research: Studies on instrumentation and methodology. Arch Pathol Lab Med 1994; 118: 1106–1109.

    CAS  PubMed  Google Scholar 

  30. DeClerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I . Measurement of plasminogen activator inhibitor 1 in biological fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71: 220–225.

    CAS  PubMed  Google Scholar 

  31. Alberti KG, Zimmet PZ . Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998; 15: 539–553.

    Article  CAS  Google Scholar 

  32. Falconer DS . Introduction to quantitative genetics, 3rd edn.: Longman Essex, UK; 1989.

    Google Scholar 

  33. Hopper JL, Mathews JD . Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet 1982; 46: 373–383.

    Article  CAS  PubMed  Google Scholar 

  34. Lange K, Boehnke M . Extensions to pedigree analysis IV. Covariance components models for multivariate traits. Am J Med Genet 1983; 35: 816–826.

    Google Scholar 

  35. Amos CI . Robust variance-components approach for assessing genetic linkage in pedigrees. Am J of Hum Genet 1994; 54: 535–543.

    CAS  Google Scholar 

  36. Almasy L, Blangero J . Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198–1211.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Self SG, Liang KY . Asymptotic properties of maximum likelihood ratio tests under nonstandard conditions. J Am Statist Assoc 1987; 82: 605–610.

    Article  Google Scholar 

  38. Blangero J, Williams JT, Almasy L . Robust LOD scores for variance component-based linkage analysis. Genet Epidemiol 2000; 19(Suppl 1): S8–S14.

    Article  PubMed  Google Scholar 

  39. Bjorntorp P, Rosmond R . Visceral obesity and diabetes. Drugs Suppl 1999;1: 13–18.

    Article  Google Scholar 

  40. Seidell JC . Obesity, insulin resistance and diabetes—a worldwide epidemic. Br J Nutr 2000; 83(Suppl 1): S5–S8.

    CAS  PubMed  Google Scholar 

  41. Reaven GM . Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism 1987; 36:(Suppl 1): 1–8.

    Article  CAS  PubMed  Google Scholar 

  42. Howard BV, Howard WJ . Dyslipidemia in non-insulin-dependent diabetes mellitus. Endocrine Rev 1994; 15: 263–274.

    CAS  Google Scholar 

  43. Larsen JL . Dyslipidemia in diabetes: a comprehensive analysis. Adv Nurse Pract 1998; 6: 36–43.

    CAS  PubMed  Google Scholar 

  44. Haffner SM . Management of dyslipidemia in adults with diabetes. Diabetes Care 1998; 21: 160–178.

    Article  CAS  PubMed  Google Scholar 

  45. Fujii S, Goto D, Zaman T, Ishimori N, Watano K, Kaneko T, Okada H, Makiguchi M, Nakagawa T, Kitabatake A . Diminished fibrinolysis and thrombosis: clinical implications for accelerated atherosclerosis. J Atheroscler Thromb 1998; 5: 76–81.

    Article  CAS  PubMed  Google Scholar 

  46. Bastard JP, Pieroni L, Hainque B . Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab Res Rev 2000; 16: 192–201.

    Article  CAS  PubMed  Google Scholar 

  47. Hall JE, Brands MW, Henegar JR . Mechanisms of hypertension and kidney diseases in obesity. Ann NY Acad Sci 1999; 892: 91–107.

    Article  CAS  PubMed  Google Scholar 

  48. Ferrannini E, Haffner SM, Mitchell BD, Stern MP . Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416–422.

    Article  CAS  PubMed  Google Scholar 

  49. Despres JP, Lamarche B, Mauriege P, Cantin B, Lupien PJ, Dagena GR . Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952–957.

    Article  CAS  PubMed  Google Scholar 

  50. Mitchell BD, Kammerer CK, Mahaney MC, Blangero J, Comuzzie AG, Atwood LD, Haffner SM, Stern MP, MacCluer JW . Genetic analysis of the IRS pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol 1996; 16: 281–288.

    Article  CAS  PubMed  Google Scholar 

  51. Carmelli, Cardon LR, Fabsitz R . Clustering of hypertension, diabetes, and obesity in adult male twins: Same genes or same environments? Am J Hum Genet 1994; 55: 566–573.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Edwards KL, Newman B, Mayer E, Selby JV, Krauss RM, Austin MA . Heritability of factors of the insulin resistance syndrome in women twins. Genet Epidiol 1997; 14: 241–253.

    Article  CAS  Google Scholar 

  53. Duggirala R, Williams K, Arya R, Blangero J, Stern MP . Genetic factors underlying the Insulin Resistance Syndrome in nondiabetic Mexican Americans. Am J Hum Biol 2000; 12: 274.

    Article  Google Scholar 

  54. Mahaney MC, Blangero J, Comuzzie AG, Van de Berg JL, Stern MP, MacCluer JW . Plasma HDL cholesterol, triglycerides, and adiposity: a quantitative test of the cojoint trait hypothesis in the San Antonio Family Heart Study. Circulation 1995; 92: 3240–3248.

    Article  CAS  PubMed  Google Scholar 

  55. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS . A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166–2170.

    Article  CAS  PubMed  Google Scholar 

  56. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, Davis CE, Heiss G . Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and overall obesity in a general population. Atherosclerosis risk in communities study investigators. Metabolism 1996; 45: 699–706.

    Article  CAS  PubMed  Google Scholar 

  57. Garvey WT, Hermayer KL . Clinical implications of the insulin resistance syndrome. Clin Cornerstone 1998; 1: 13–28.

    Article  CAS  PubMed  Google Scholar 

  58. Tenkanen L, Manttari M, Manninen V . Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study. Circulation 1995; 92: 1779–1785.

    Article  CAS  PubMed  Google Scholar 

  59. Stec JJ, Silberashatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PFW, Muller JE, D'Agostino RB . Association of fibrinogen with cardiovascular disease risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000; 102: 1634–1638.

    Article  CAS  PubMed  Google Scholar 

  60. Lam TH, Liu LJ, Janus ED, Lam KS, Hedley AJ . Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Med 2000; 17: 798–806.

    Article  CAS  Google Scholar 

  61. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarro ME, Azen SP, Cashin-Hemphill L . Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233–3240.

    Article  CAS  PubMed  Google Scholar 

  62. MacAuley D, McCrumm EE, Stott G, Evans AE, Duly E, Trinick T, Sweeney K, Boreham CA . Physical activity, lipids, apolipoproteins, and Lp(a) in the Northern Ireland Health and Activity Survey. Med Sci Sports Exerc 1996; 28: 720–736.

    Article  CAS  PubMed  Google Scholar 

  63. Gensini GF, Comeglio M, Colella A . Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 1998; 19(Suppl A): A53–A61.

    PubMed  Google Scholar 

  64. Haffner SM . Diabetes, hyperlipidemia, and coronary artery disease. Am J Cardiol 1999; 83: 17F–21F.

    Article  CAS  PubMed  Google Scholar 

  65. Wagner AM, Perez A, Calvo F, Bonet R, Castellvi A, Ordonez, J . Apolipoprotein (B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetes patients. Diabetes Care 1999; 22: 812–817.

    Article  CAS  PubMed  Google Scholar 

  66. Luc G, Bard J, Evans A, Arveiler D, Ruidavets J, Amouyel P, Ducimetiere P . The relationship between apolipoprotein AI- containing lipoprotein fractions and environmental factors: the PRIME Study. Atherosclerosis 2000; 152: 399–405.

    Article  CAS  PubMed  Google Scholar 

  67. Imamura H, Uchida K, Kobata D . Relationship of cigarette smoking with blood pressure, serum lipids, and lipoproteins in young Japanese women. Clin Exp Pharmacol Physiol 2000; 27: 364–369.

    Article  CAS  PubMed  Google Scholar 

  68. Tuut M, Hense H . Smoking, other risk factors and fibrinogen levels. Evidence of effect modification. Ann Epidemiol 2001; 11: 232–238.

    Article  CAS  PubMed  Google Scholar 

  69. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ . Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br Med J 1999; 319: 1523–1528.

    Article  CAS  Google Scholar 

  70. Mennen LI, Balkau B, Vol S, Caces E, Eshwege E . Fibrinogen: a possible link between alcohol consumption and cardiovascular disease. Arterioscler Thromb Vasc Biol 1999; 19: 887–892.

    Article  CAS  PubMed  Google Scholar 

  71. James S, Vorster HH, Venter CS, Kruger HS, Nell TA, Veldman FJ, Ubbink JB . Nutritional status influences plasma fibrinogen concentration: Evidence from the THUSA Survey. Thromb Res 2000; 98: 383–394.

    Article  CAS  PubMed  Google Scholar 

  72. Di Minno G, Piemontino U, Cerbone AM . Nutrition and thrombogenic factors. Nutr Metab Cardiovasc Dis 1999; 9(4 Suppl): 16–20.

    CAS  PubMed  Google Scholar 

  73. Koenig W, Ernst E . Exercise and thrombosis. Coronary Artery Dis 2000; 11: 123–127.

    Article  CAS  Google Scholar 

  74. Vanninen E, Laitinen J, Uusitupa M . Physical activity and fibrinogen concentration in newly diagnosed NIDDM. Diabetes Care 1994; 17: 1031–1038.

    Article  CAS  PubMed  Google Scholar 

  75. Lee ET, Welty TK, Cowan LD, Rhoades DA, Devereux R, Go O, Fabsitz R, Wang W, Howard BV . Incidence of diabetes mellitus in American Indians of three geographic areas: the Strong Heart Study. Diabetes Care 2002; 25: 49–54.

    Article  PubMed  Google Scholar 

  76. Yurgalevitch SM, Kriska AM, Welty TK, Go O, Robbins DC, Howard BV . Physical activity and lipids and lipoproteins in American Indians ages 45–74. Med Sci Sports Exerc 1998; 30: 543–549.

    Article  CAS  PubMed  Google Scholar 

  77. Wallenstein S, Zucker C, Fleiss J . Some statistical methods useful in circulation research. Circ Res 1980; 47: 1–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the Strong Heart Family Study participants. Without their participation, this project would not have been possible. In addition, the cooperation of the Indian Health Service hospitals and clinics, and the directors of the Strong Heart Study clinics, Betty Jarvis, Marcia O'Leary, Dr Tauqeer Ali, Alan Crawford, and the many collaborators and staff of the Strong Heart Study have made this project possible. We also thank Drs John Blangero, Laura Almasy, Tony Comuzzie, and Lisa Martin for their generous contribution to this research. This research was conducted while author (KEN) was a postdoctoral fellow at the Southwest Foundation for Biomedical Research and was funded by a cooperative agreement that includes Grants U01 HL65520, U01 HL41642, U01 HL41652, U01 HL41654, U01 HL65521 from the National Heart, Lung, and Blood Institute. The views expressed in this paper are those of the authors and do not necessarily reflect those of the Indian Health Service.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K E North.

Rights and permissions

Reprints and permissions

About this article

Cite this article

North, K., Williams, J., Welty, T. et al. Evidence for joint action of genes on diabetes status and CVD risk factors in American Indians: the Strong Heart Family Study. Int J Obes 27, 491–497 (2003). https://doi.org/10.1038/sj.ijo.0802261

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802261

Keywords

This article is cited by

Search

Quick links